Correlating the Clinical and CT Severity of COVID-19 patients with the Inflammatory markers and Co-morbidities
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/11/028836
- Lead Sponsor
- Aparna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients > 18 years who have tested positive for COVID-19 either by RT-PCR or CB-NAAT
Exclusion Criteria
Patients < 18 years.
Patients with consolidation/pneumonia due to other organisms than the SARS CoV-2 virus.
Patients with coexisting infections apart from COVID-19.
Patients with chronically elevated inflammatory markers due to other inflammatory conditions, like Autoimmune conditions.
Pregnant patients
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Obtaining correlation between the inflammatory markers, comorbidities and the CT and Clinical severity of COVID-19 patients.Timepoint: At Baseline
- Secondary Outcome Measures
Name Time Method To develop a new classification system for COVID-19 patients by including their comorbidities and inflammatory marker levels into account.Timepoint: 1 year